Loading organizations...
§ Private Profile · Munich, Bayern, Germany
AI-powered precision medicine platform analyzing retinal scans to provide therapy recommendations for ophthalmologists, focused on retinal diseases.
Based in Munich, Germany, deepeye develops an AI-powered precision medicine platform that analyzes retinal scans to provide customized therapy recommendations for ophthalmologists treating diseases like age-related macular degeneration. The medical device software company has validated its tele-ophthalmic network approach on over 2,466 patients to forecast treatment responses and improve therapy adherence. Operating within the healthcare sector, the startup generates revenue by licensing its clinical decision support software to eye clinics and providing real-world data analytics services to pharmaceutical companies. The enterprise has raised €2.5 million in seed funding from venture capital firms including YZR Capital and Bayern Kapital. Additionally, the firm collaborates with major industry partners such as Novartis, Bayer, and Roche to develop prognostic AI tools and conduct research on retinal therapy outcomes. deepeye was founded in 2021 by Manuel Opitz and Ratko Petrovic.
deepeye has raised $2.7M across 1 funding round.
deepeye has raised $2.7M in total across 1 funding round.
deepeye has raised $2.7M in total across 1 funding round.
deepeye's investors include YZR Capital, Arve Capital, Monika Steger.
deepeye has raised $2.7M across 1 funding round. Most recently, it raised $2.7M Seed in November 2023.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Nov 7, 2023 | $2.7M Seed | YZR Capital | Arve Capital, Monika Steger | Announced |